OFFICIAL PUBLICATION OF

by its subsidiary APPco

First OTC cannabis by early 2023?

David Rowley 06/10/2022

Wellnex Life hoping for SAS OK by year’s end with S3 approval to follow in next quarter - and a market potentially worth "billions" ASX-listed health and wellness outfit Wellnex is aiming to be the first company to produce and market an over-the-counter cannabis preparation, ramping up its efforts for S3 approval for a market

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

First OTC cannabis by early 2023?

Previous World news wrapup: 6 October 2022

Next Fentanyl use skyrockets

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous World news wrapup: 6 October 2022

Next Fentanyl use skyrockets

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.